Sun Pharma Strikes $11.75 Billion Organon Deal in India’s Biggest Pharma Acquisition
Mumbai — Sun Pharmaceutical Industries will acquire U.S.-based drugmaker Organon & Co in an all-cash deal valued at about $11.75
Read More
Factual Version of a Story
Indian pharmaceutical industry
Lupin Reports Impressive Profit Surge Driven by Strong Demand for Respiratory Drugs
Lupin records a major leap in quarterly profits, powered by strong global demand for its respiratory medicines and continued expansion
Read More
Aurobindo Pharma Reports Steady Profit Growth Driven by Domestic and Global Demand
Aurobindo Pharma has reported a rise in profit for the second quarter of the financial year, reflecting steady domestic demand
Read More